Artificial Pancreas Market - Global Professional Analysis and Forecast to 2026

Oct 22, 2019  |  178 PAGES  |  REPORT CODE: CMM221020
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Artificial Pancreas market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 13.9% during the forecast period.

This report presents the market size and development trends by detailing the Artificial Pancreas market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Artificial Pancreas market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Artificial Pancreas industry and will help you to build a panoramic view of the industrial development.

Artificial Pancreas Market, By Type:

  • Type 1

  • Type 2

  • Type 3

Artificial Pancreas Market, By Application:

  • End-User 1

  • End-User 2

  • End-User 3

Some of the leading players are as follows:

  • Thoratec Corp. (USA)

  • F.Hoffmann-La Roche Ltd. (Switzerland)

  • Abbott Diabetes Care, Inc. (USA)

  • Nikkiso Co., Ltd. (Japan)

  • Jarvik Heart, Inc. (USA)

  • Terumo Heart, Inc. (USA)

  • SynCardia Systems, Inc. (USA)

  • Medtronic, Inc. (USA)

  • Xenios AG (Germany)

  • Fresenius Medical Care AG & Co. KGaA (Germany)

  • Vital Therapies, Inc. (USA)

  • Toray Medical Co., Ltd. (Japan)

  • HeartWare International, Inc. (USA)

  • Baxter International, Inc. (USA)

  • Nipro Corporation (Japan)

  • Asahi Kasei Medical Co., Ltd. (Japan)

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Artificial Pancreas Market: Technology Type Analysis

  • 4.1 Artificial Pancreas Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Artificial Pancreas Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Type 1

    • 4.3.2 Type 2

    • 4.3.3 Type 3

5 Artificial Pancreas Market: Product Analysis

  • 5.1 Artificial Pancreas Product Market Share Analysis, 2018 & 2026

  • 5.2 Artificial Pancreas Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Artificial Pancreas Market: Application Analysis

  • 6.1 Artificial Pancreas Application Market Share Analysis, 2018 & 2026

  • 6.2 Artificial Pancreas Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 End-User 1

    • 6.3.2 End-User 1

    • 6.3.3 End-User 3

7 Artificial Pancreas Market: Regional Analysis

  • 7.1 Artificial Pancreas Regional Market Share Analysis, 2018 & 2026

  • 7.2 Artificial Pancreas Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Thoratec Corp. (USA)

    • 9.1.1 Thoratec Corp. (USA) Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 F.Hoffmann-La Roche Ltd. (Switzerland)

    • 9.2.1 F.Hoffmann-La Roche Ltd. (Switzerland) Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Abbott Diabetes Care, Inc. (USA)

    • 9.3.1 Abbott Diabetes Care, Inc. (USA) Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Nikkiso Co., Ltd. (Japan)

    • 9.4.1 Nikkiso Co., Ltd. (Japan) Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Jarvik Heart, Inc. (USA)

    • 9.5.1 Jarvik Heart, Inc. (USA) Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Terumo Heart, Inc. (USA)

    • 9.6.1 Terumo Heart, Inc. (USA) Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 SynCardia Systems, Inc. (USA)

    • 9.7.1 SynCardia Systems, Inc. (USA) Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Medtronic, Inc. (USA)

    • 9.8.1 Medtronic, Inc. (USA) Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Xenios AG (Germany)

    • 9.9.1 Xenios AG (Germany) Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Fresenius Medical Care AG & Co. KGaA (Germany)

    • 9.10.1 Fresenius Medical Care AG & Co. KGaA (Germany) Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Vital Therapies, Inc. (USA)

    • 9.11.1 Vital Therapies, Inc. (USA) Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Toray Medical Co., Ltd. (Japan)

    • 9.12.1 Toray Medical Co., Ltd. (Japan) Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 HeartWare International, Inc. (USA)

    • 9.13.1 HeartWare International, Inc. (USA) Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Baxter International, Inc. (USA)

    • 9.14.1 Baxter International, Inc. (USA) Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Nipro Corporation (Japan)

    • 9.15.1 Nipro Corporation (Japan) Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Asahi Kasei Medical Co., Ltd. (Japan)

    • 9.16.1 Asahi Kasei Medical Co., Ltd. (Japan) Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

 

The List of Tables and Figures (Totals 67 Figures and 155 Tables)

  • Figure Type 1 Artificial Pancreas market, 2015 - 2026 (USD Million)

  • Figure Type 2 Artificial Pancreas market, 2015 - 2026 (USD Million)

  • Figure Type 3 Artificial Pancreas market, 2015 - 2026 (USD Million)

  • Figure End-User 1 market, 2015 - 2026 (USD Million)

  • Figure End-User 2 market, 2015 - 2026 (USD Million)

  • Figure End-User 3 market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Artificial Pancreas market, by country, 2015 - 2026 (USD Million)

  • Table North America Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table North America Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table North America Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table Canada Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table Canada Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table Europe Artificial Pancreas market, by country, 2015 - 2026 (USD Million)

  • Table Europe Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table Europe Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table Europe Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table Germany Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table Germany Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table France Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table France Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table Italy Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table Italy Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table Spain Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table Spain Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Artificial Pancreas market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table China Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table China Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table Japan Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table Japan Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table India Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table India Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Artificial Pancreas market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table MEA Artificial Pancreas market, by country, 2015 - 2026 (USD Million)

  • Table MEA Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table MEA Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table MEA Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Artificial Pancreas market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Artificial Pancreas market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Artificial Pancreas market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Thoratec Corp. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table F.Hoffmann-La Roche Ltd. (Switzerland) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Diabetes Care, Inc. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Nikkiso Co., Ltd. (Japan) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Jarvik Heart, Inc. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Terumo Heart, Inc. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table SynCardia Systems, Inc. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Medtronic, Inc. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Xenios AG (Germany) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Fresenius Medical Care AG & Co. KGaA (Germany) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Vital Therapies, Inc. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Toray Medical Co., Ltd. (Japan) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table HeartWare International, Inc. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Baxter International, Inc. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Nipro Corporation (Japan) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Asahi Kasei Medical Co., Ltd. (Japan) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top